{
  "docId": "019de070-182a-72ba-952e-2b048c610e12",
  "docSlug": "cea7bfa85dc209a87c7b2adf6cd4697f",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 22,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "roadmap",
  "function": "show_traction",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses a 3-column layout to map programs to their respective 2020 achievements.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-182a-72ba-952e-2b048c610e12/3",
  "deckHref": "/decks/019de070-182a-72ba-952e-2b048c610e12",
  "deckJsonHref": "/decks/019de070-182a-72ba-952e-2b048c610e12.json",
  "deckAnchorHref": "/decks/019de070-182a-72ba-952e-2b048c610e12#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.26,
        "x": 0.67,
        "y": 0.67
      },
      "kind": "list",
      "text": "$138m financing to support clinical and platform programs; runway through 2022",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22e73c7d-d19a-494c-b63d-48c4d3e3a528",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.26,
        "x": 0.37,
        "y": 0.67
      },
      "kind": "list",
      "text": "CTA approved by MHRA; Ph 1/2 first patient dosed",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "884ced51-3c2a-4f39-b7d1-57ec10e576d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.26,
        "x": 0.07,
        "y": 0.67
      },
      "kind": "list",
      "text": "1-year OLE data; Pivotal Ph 3 enrollment completion; Topline Ph 3 data (1Q21)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9557168a-9e9b-482b-b7e1-e18c73487fe6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.26,
        "x": 0.67,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "Enzyme Therapeutics Platform: Rare metabolic-disease, monogenic focus. Most advanced program in Cystinuria",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ff74875-72ea-4ef8-890a-3967082440c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.26,
        "x": 0.07,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "Pegzilarginase in Arginine 1 Deficiency: Enhanced human arginase that enzymatically lowers levels of the arginine. PEACE – pivotal Phase 3 trial enrolling",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "52bc8ef3-96f9-44dd-94a5-cc0b5cf9c43e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.26,
        "x": 0.37,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "ACN00177 in Homocystinuria: Novel recombinant human enzyme that degrades the amino acid homocysteine. Phase 1/2 trial ready for initiation",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "93e9bf81-77c8-4ae0-840d-d219402ad0fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "Advancing Programs Set Stage for Transformative 2021",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f473fb90-840e-461f-85f4-7eae5ceaf8e0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.86,
        "x": 0.07,
        "y": 0.585
      },
      "kind": "title",
      "text": "2020 Momentum",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f123ff03-7d74-4188-b654-2db7abcf9b8a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}